The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients

PHASE4UnknownINTERVENTIONAL
Enrollment

444

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2015

Conditions
Depression
Interventions
DRUG

Escitalopram

first week:5mg 2nd week\~12 week:10mg

DRUG

sugar pill

first week:5mg 2nd week\~12 weeks:10mg

Trial Locations (16)

200-722

Kangwon National University Hospital, Chuncheon

412-270

Kwandong University College of Medicine Myongji Hospital, Gyeonggi-do

425-707

Korea University Ansan Hospital, Ansan

471-701

Hanyang University Guri Hospital, Guri-si

701-600

Daegu Fatima Hospital, Daegu

410-773

Dongguk University International Hospital, Goyang

430-070

Hallym Univesity Sacred Heart Hospital, Anyang

602-715

Dong-A University Hospital, Busan

700-712

Dongsan Medical Center, Daegu

301-721

Chungnam National University Hospital, Daejeon

501-717

Chosun University Hospital, Gwangju

400-103

Inha University Hospital, Inchon

120-752

Severance Hospital, Seoul

130-702

KyungHee University Medical Center, Seoul

138-736

Asan Medical Center, Seoul

143-729

Konkuk Univ. Hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

Dong-A ST Co., Ltd.

INDUSTRY

lead

Asan Medical Center

OTHER

NCT01278498 - The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients | Biotech Hunter | Biotech Hunter